SCHEMBL14166245

SCHEMBL14166245

O=C(O)NC(c1ccccc1)c1cc(OCCCCCCCCC2OCCO2)cc(-c2ccccc2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 5/20 0.40
BRD4 O60885 1/20 0.40
HRH3 Q9Y5N1 12/20 0.38
KMT2A Q03164 2/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
HDAC2 Q92769 4/20 0.36
HDAC3 O15379 3/20 0.36
HDAC4 P56524 3/20 0.36
HDAC7 Q8WUI4 3/20 0.36
HDAC10 Q969S8 3/20 0.36
HDAC11 Q96DB2 3/20 0.36
HDAC8 Q9BY41 3/20 0.36
HDAC6 Q9UBN7 3/20 0.36
HDAC9 Q9UKV0 3/20 0.36
HDAC5 Q9UQL6 3/20 0.36
KCNH2 Q12809 2/20 0.35
HRH4 Q9H3N8 2/20 0.35
HRH1 P35367 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14166374 0.88 HDAC1 (0.36) HDAC1BRD4HRH3KMT2AALDH1A1
SCHEMBL14166237 0.88 MEN1 (0.44) HRH3KMT2AALDH1A1MEN1TAAR1
SCHEMBL17074623 0.88 MEN1 (0.44) HRH3KMT2AALDH1A1MEN1TAAR1
SCHEMBL14706786 0.82 CHRM3 (0.58)
SCHEMBL14241185 0.81 CHRM3 (0.40) HRH3
SCHEMBL14240838 0.76 MEN1 (0.42) KMT2AALDH1A1MEN1TAAR1
SCHEMBL14694815 0.73 HRH3 (0.37) HRH3
SCHEMBL14694819 0.73 HRH3 (0.37) HRH3
SCHEMBL14694816 0.73 HRH3 (0.37) HRH3
SCHEMBL14706817 0.72 CHRM3 (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2718280-B1 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARMA SPA (IT) 2015-09-16 EP disclosed
EP-2718280-A1 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY Chiesi Farmaceutici S.p.A. (IT) 2014-04-16 EP disclosed
WO-2012168359-A1 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARMACEUTICI S.P.A. (IT) 2012-12-13 WO disclosed